Live from the NIH registry
Studies recruiting near Santa Ana right now
Top 25 of 1,911 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
City of Hope National Medical Center — Duarte, California (28.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (4.5 mi)
· Sponsor: Takeda
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Orange County Retina Med Group — Santa Ana, California (1.0 mi)
· Sponsor: Genentech, Inc.
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Santa Ana, California (1.0 mi)
· Sponsor: Axsome Therapeutics, Inc.
Effect of Electro-Acupuncture on Blood Pressure
Hypertension
N/A
Interventional 160 participants sought
UCIMedical Center — Orange, California (3.9 mi)
· Sponsor: University of California, Irvine
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Glaucoma, Ocular Surface Disease
N/A
Observational 75 participants sought
Doheny Eye Center UCLA — Fountain Valley, California (4.5 mi)
· Sponsor: University of California, Los Angeles
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Colorectal Cancer Metastatic
Phase 2
Interventional 20 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (8.6 mi)
· Sponsor: Buzzard Pharmaceuticals
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
ATP Clinical Research Inc. — Irvine, California (5.7 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL)
Phase 1
Interventional 106 participants sought
City of Hope — Duarte, California (28.4 mi)
· Sponsor: Umoja Biopharma
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Providence Medical Foundation ( Site 0141) — Fullerton, California (9.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
University of California Irvine — Orange, California (3.9 mi)
· Sponsor: Nurix Therapeutics, Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California (3.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1
Interventional 36 participants sought
City of Hope Medical Center — Duarte, California (28.4 mi)
· Sponsor: PeproMene Bio, Inc.
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Advanced Medical Research — La Palma, California (12.1 mi)
· Sponsor: Novartis Pharmaceuticals
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center — Torrance, California (27.2 mi)
· Sponsor: Synairgen Research Ltd.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Dream Team Clinical Research — Pomona, California (23.2 mi)
· Sponsor: Crystalys Therapeutics
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
University of California Irvine Medical Center — Orange, California (3.9 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Urothelial Carcinoma, Muscle-invasive Bladder Cancer
Phase 2
Interventional 23 participants sought
Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California (3.9 mi)
· Sponsor: University of California, Irvine
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Phase 2, Phase 3
Interventional 740 participants sought
Corxel Investigational Site — Long Beach, California (17.8 mi)
· Sponsor: Corxel Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
SDS Clinical Trials, Inc-California-Santa Ana — Santa Ana, California (1.0 mi)
· Sponsor: Eisai Inc.
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
Phase 1
Interventional 1,006 participants sought
Providence Medical Foundation — Anaheim, California (7.1 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment
Opioid Use Disorder
N/A
Interventional 3,492 participants sought
University of California Irvine Emergency Department — Irvine, California (5.7 mi)
· Sponsor: University of California, Davis
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
University of California - Irvine Medical Center — Irvine, California (5.7 mi)
· Sponsor: Steba Biotech S.A.
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California (3.9 mi)
· Sponsor: National Cancer Institute (NCI)
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Brain Cancer, Breast Cancer
N/A
Observational 7,000 participants sought
City of Hope — Duarte, California (28.4 mi)
· Sponsor: Adela, Inc